non-small cell lung cancer
Korea's IMBDx Explores NSCLC Therapy Guidance, Multi-Cancer Early Detection for Liquid Biopsy Tech
Premium
The company recently published data on its NGS-based pleural effusion liquid biopsy panel and is launching a large multimodal MCED study in Korea.
Natera MRD Test Receives MolDx Coverage for Lung Cancer Surveillance
The test has met coverage requirements for use with patients with non-small cell lung cancer with resectable or unresectable disease in the surveillance setting.
Imagene, Tempus AI to Collaborate on AI-Based Lung Cancer Diagnostics
Imagene's AI-based multigene panel for predicting non-small cell lung cancer biomarkers from biopsy images will be combined with Tempus' real-world data.
CellCarta, Biofidelity Partner to Offer Lung Cancer Assay for Clinical Trials
CellCarta will validate Biofidelity's Aspyre Lung assay in its European and US labs and will hold nonexclusive rights to use it in global clinical trials.
Volition Eyes East Asia Expansion With Nucleosome-Based Blood Test for Lung Cancer Screening
Premium
The firm hopes to include its lung cancer assay in Taiwan's national cancer screening program while developing sepsis and ovarian cancer assays.